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both radiations. Clustered DNA damage poses serious 
problems for the DNA repair and error-prone repair of DNA 
damage is associated with cancer induction. Increased 
damage complexity following exposure to mixed beams will 
suggest a higher than expected risk of cancer induction in 
modern radiotherapy. The results are consistent with the 
previous studies carried out at SU with different cell types 
and different biological assays. A synergistic interaction of 
the beam components was observed at the level of 
micronuclei, gammaH2AX foci and chromosomal aberrations. 
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Purpose or Objective: Due to its higher precision in tumor 
targeting, proton therapy could become the treatment of 
choice for head and neck cancer (HNC). Recent studies have 
shown that proton irradiation suppresses angiogenic genes 
and impairs tumor cell invasion/growth. According to the 
type of radiation, dose and fractionation, the objective of 
our study was to investigate the effect of proton (P+) versus 
photon (X) irradiations in squamous cells carcinoma (SCC), in 
respect of their proliferation, genes expression and proteins 
secretion involved in proliferation, angio/lymphangenesis, 
metastasis and anti-tumor immunity. 
 
Material and Methods: Human SCC CAL33 cells were 
irradiated 1 to 3 times and evaluated on their proliferation 
(Cell counting), genes expression (qPCR) for proliferation 
(TRF2, PLK1), angio/lymphangiogenic (VEGF-A, VEGF-C, 
VEGF-D) inflammatory (IL6, IL8, CCL2, CXCL12) and immune 
(PD-L1) responses.and protein synthesis (ELISA). 
 
Results: Cell proliferation was evaluated at 48h and at 3 
weeks after 1 irradiation and showed a significant decreased 
in both X and P+, as compared to control but more important 
in P+. After 3 irradiations, cell proliferation at 48h was 
reversed and more decreased in X vs P+. Genes expression 
was investigated at 48h after 1 and 3 irradiations at 2 and 8 
Gy. After 1 irradiation, the prevalence of gene expression 
levels associated with a poor outcome was higher in X than 
P+ at 8 Gy. After 3 irradiations, genes expression was 
increased for all but more important for P+ at 8 Gy. The 
highest expression was noted for VEGF-C (2 to 10 fold 
increase). The most frequent overexpression was noted for 
PD-L1. VEGF-C protein induction 48h after 1 and 3 
irradiations was increased in both X and P+ groups but 
decreased in high dose P+, as compared to X. 
 
Conclusion: Cell proliferation activity is in favor of P+ after a 
single irradiation, and X after multiple irradiations. Genes 
expression are overall increased in both X and P+, in a dose 
and fraction dependent manner, implicated in proliferation 
(TRF2), angio/lymphangiogenic (VEGF-A, VEGF-C, VEGF-D) 
and immune (PD-L1) responses. VEGF-C protein induction is 
increased after both X and P+ single and multiple 
irradiations, but in favor of P+, suggesting a lower 
lymphangiogenesis/metastatic dissemination immediately 
after P+. Our study sets the molecular basis for novel 
therapeutic approaches applicable to HNC in combination 
with X or P+ radiotherapy, such as angio/lymphangenic 
inhibitors or immune therapy as anti-PD1 or anti-PD-L1. 
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Purpose or Objective: The aim of this study was to appraise 
multiple properties for radiation therapy techniques applying 
flattening filter-free (3F) and flattening filter (2F) beam to 
the radiation therapy. 
 
Material and Methods: Alderson rando phantom was scanned 
for computed tomography images. Treatment plans for 
intensity modulated radiation therapy (IMRT), volumetric 
modulated arc therapy (VMAT) and stereotactic body 
radiation therapy(SBRT) with 3F and 2F beam were designed 
for prostate cancer. To evaluate the differences between the 
3F and 2F beam, total monitor units (MUs), beam on time 
(BOT) and gantry rotation time (GRT) were evaluated and 
measured with TrueBeam™ STx and Surveillance And 
Measurement (SAM) 940 detector was used for photoneutron 
emitted by using 3F and 2F. 
 
Results: In using 3F beam, total MUs in IMRT plan increased 
the highest up to 34.0% and in the test of BOT and GRT, the 
values in SBRT plan by 3F beam decreased the lowest 39.8, 
38.6% respectively. The values of photoneutron occurrence in 
SBRT plan using 3F beam decreased the lowest 48.1%. 
 
Conclusion: According as the results, total MUs increased by 
using 3F beam than 2F beam in all treatment plans but BOT, 
GRT and photoneutron decreased by using 3F beam. From 
above the results, using 3F beam can have an effect on 
decreasing intra-fraction setup error and risk of radiation-
induced secondary malignancy. 
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Purpose or Objective: Patients with Small-Cell Lung Cancer 
(SCLC) have a high risk of developing brain metastasis. 
Prophylactic Cranial Irradiation (PCI), is applied to SCLC 
patients that response to chemotherapy. It is well known that 
PCI is associated with an increase in median overall survival. 
There are approximately 84 incidences per year in central 
region DK. Radiotherapy (RT) to this group of patients is 
conventionally performed using opposed MLC defined static 
fields. However, treatment planning can be time consuming. 
The aim of this study is to evaluate time-effectiveness, by 
changing the treatment technique from conventional to IMRT 
based treatment planning of PCI patients. 
 
Material and Methods: This retrospective study included 
twenty SCLC patients, all treated with conventional planned 
PCI. Each patient received 25 Gray in 10 fractions. An IMRT 
template was made (Eclipse Version 11.0, Varian Medical 
Systems, Palo Alto, CA) and for each patient an IMRT plan 
was generated by one IMRT optimization. One intermediate 
dose calculation was performed during optimization before 
the final dose calculation. The contoured structures used for 
comparison between IMRT and conventional planning were: 
ITV, PTV and left/right lens. The plans were evaluated and 
compared on; max- and minimum doses, the mean/maximum 
doses to the lenses, and the homogeneity index (HI). The HI 
was defined by D5%/D95%. Quality assurance of the IMRT 
plans was performed by recording Portal Dosimetry Images 
